Gene Logic Signs Agreement with GE Healthcare to Distribute New Gene Expression Analysis System to Academic, Government and Othe
July 19 2005 - 11:52AM
Business Wire
Gene Logic Inc. (NASDAQ:GLGC) announced today it has signed an
agreement with GE Healthcare for global distribution of Gene
Logic's new SCIANTIS(TM) System, an online gene expression analysis
system developed for use by academic, government and other
non-profit research organizations. GE Healthcare will distribute
the system in 32 countries and will be the exclusive distributor in
Japan. Financial details of the agreement were not disclosed. The
SCIANTIS System is user friendly, browser based, and designed to
help researchers quickly and easily profile the expression of
human, rat and mouse genes in normal and diseased tissues in order
to better understand the relationship of gene expression to
biological function and mechanisms of disease. The system is based
on Gene Logic's gene expression reference database, which allows
accurate expression comparisons due to the Company's
industry-leading quality control metrics and sample processing
automation, which are employed at its state-of-the-art facility.
The SCIANTIS System features: -- Gene expression profiles from more
than 6,000 human, rat, and mouse tissue samples curated by expert
pathologists into more than 800 sample sets. -- Summary expression
data for more than 30,000 genes in each sample set. -- Proprietary
software that allows researchers to quickly visualize data of
interest and generate reports regarding gene expression across a
wide variety of cell lines or tissues. -- Data segmented into five
disease areas, including inflammation, cardiovascular disease,
oncology, central nervous system disorders, and metabolic diseases.
Dennis Rossi, senior vice president and general manager, Genomics
for Gene Logic, said, "We designed the SCIANTIS System for the
thousands of academic and university researchers who have not had
access to the same gene expression analysis systems as their
industry counterparts. We have coupled this new product with GE
Healthcare's strong brand and powerful worldwide marketing and
sales capabilities. We are positioned to significantly broaden our
customer base in alliance with one of the largest and best-known
corporations in the world, through GE Healthcare's innovative
marketing, web commerce, direct selling and broad distributor
network." Ger Brophy, head of product acquisition and licensing, GE
Healthcare said, "We are excited to work with Gene Logic, a leader
in genomics services, to distribute the SCIANTIS System, an
innovative and effective way for researchers to more efficiently
analyze genetic expression data. The SCIANTIS System is a valuable
addition to the technologies and services GE Healthcare offers to
our life sciences customers." Gene Logic Overview Gene Logic
aspires to be the most valued drug development solutions partner to
the pharmaceutical industry. Gene Logic applies its broad and
unique mix of technologies, talent and methodologies to work on
behalf of its partners to enable pharmaceutical and biotechnology
companies to make more informed, more reliable and more predictive
decisions at each point in the highly complex and costly drug
development process. For more information, visit www.genelogic.com
or call toll-free - 1/800/GENELOGIC. About GE Healthcare GE
Healthcare provides transformational medical technologies that will
shape a new age of patient care. GE Healthcare's expertise in
medical imaging and information technologies, medical diagnostics,
patient monitoring systems, disease research, drug discovery and
biopharmaceutical manufacturing technologies is dedicated to
detecting disease earlier and helping physicians tailor treatment
for individual patients. GE Healthcare offers a broad range of
services to improve productivity in healthcare and enable
healthcare providers to better diagnose, treat and manage patients
with conditions such as cancer, neurological and cardiovascular
diseases. GE Healthcare is a $14 billion unit of General Electric
Company (NYSE: GE) that is headquartered in the United Kingdom.
Worldwide, GE Healthcare employs more than 42,500 people committed
to serving healthcare professionals and their patients in more than
100 countries. For more information about GE Healthcare, visit our
website at: www.gehealthcare.com.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Aug 2023 to Aug 2024